Volume 49, Issue s1 - Supplement: IFCC WorldLab Berlin 2011

Molecular Tumor Diagnostic Advances in Clinical and Diagnostic Immunology The Brain: Biological and Cerebral Diseases New Avenues in Laboratory Diagnostics

SYM 1 Biomarkers for the Diagnosis of Cardiovascular Diseases SYM 2 Diagnostic Challenges in Liver Disease YR 1 Clinical Chemistry 2010 and Beyond: Opportunities and Challenges for the Next Decade SYM 3 Tumor Markers in Cancer IFCC 1 IFCC EMD/CPD Joint Symposium: ELearning and Distance Education in Clinical Chemistry and Laboratory Medicine SYM 4 Kidney Diseasy – Acute and Chronic DGKL 1 Role of Non-Medical Scientists in the Medical Laboratory (DGKL) WS 1 Reporting HBA1C for Monitoring and Diagnosis: The Devils's in the Detail SYM 5 From Bench to Bedside in Autoimmunity SYM 6 Diabetes WS 2 Emerging Infections at AFCB Countries EFCC 1 How to Assess the Clinical Effectiveness of Laboratory DGKL 2 Laboratory Medicine – Quo vadis? Conditions, Structure and Developmental Trends in Europe INT 2 Pitfalls in the Hemostasiologic Diagnostics: Clinical Cases SYM 7 Pharmacogenetics and Pharmagocenomics YR 2 Infectious Diseases WS 3 Oxidative Stress in Diabetes Mellitus SYM 8 Infectious Diseases IFCC 2 Biobanking and Laboratory Medicine: Two Resources for Modern Health Care SYM 9 Haematology and Anaemia WS 4 Update on Cardiac Troponin – Clinical and Laboratory Issues SYM 10 Diagnostic Use and Value of Function Test in Endocrinology SYM 11 Point of Care Testing – Practical Aspects WS 5 Lessons from the Asian-Pacific Multicenter Reference Interval Study EFCC 2 Accreditation Should Be Focused on More Than Well Organized Examinations With the Laboratory DGKL 4 Quality Management according to the German Rilibaek: An International Perspective WS 6 The 2009 Influenza Pandemic – Lessons Learned SYM 12 Biomarkers in Acute and Chronic Brain Diseases YR 3 Developments in Clinical Laboratory Practice WS 7 Clinical Pharmacogenetics SYM 13 Prenatal and Neonatal Screening IFCC 3 Standardization in Molecular Diagnostics SYM 14 Allergy Diagnostics DGKL 5 Development of a Transcripting, Proteomic and Metabolomic Database for Human Blood Cells WS 8 Molecular Diagnosis of Infection SYM 15 New Developments in Haemostasiology SYM 16 Contribution of Laboratory Medicine in Leukaemia WS 9 What Papers Will Be Preferred in the Future Related to Laboratory Medicine? Editors Point of View EFCC 3 A Scientific Approach to the Post-Analytical Phase DGKL 6 Research Funding by the Foundation of Pathobiochemistry and Molecular Diagnostics of the DGKL – 10 Years on INT 1 Challenges at the Clinical Interfaces SYM 17 New Strategies in Molecular Diagnostic SYM 18 Standardization and Quality Control Issues in Emerging and Developing Countries WS 10 Standardisation of Complex Analyte Measurements: The Clinbiotrace Project SYM 19 Current Challenges in the Pediatric Laboratory EFCC 4 Standardization of the Pre-Analytical Phase for Markers SYM 20 Vitamin D: Myth or Magic IFCC-WASPaLM WS Chronic Kidney Disease – Developing a National Testing Program WS 11 Biomarkers of Acute and Neurodegenerative Brain Damages SYM 21 New Technologies in Clinical Application SYM 22 Intertwining Emergency Medicine and Laboratory Medicine WS 12 Joint Session with IAT DMCT Trends in Therapeutic Drug Monitoring: Personalized Immunosuppression IFCC 4 Traceability, Standardisation, Harmonisation: Concepts and Implementation WS 13 Vitamin Deficiency in Elderly People: Diagnosis, Prevention and Effect on Age-Related Diseases WS 14 Novel Insights in Iron Metabolism: Implications for Diagnostic Medicine

Clinical and Economic Advances in Prostate Cancer Diagnosis The Value of Improved Workflow Solutions Autonomous Biosensors – Technologies that Help to Bring Biomarkers to the Patient The Clinical Utility of Multiplex Biochips for the Detection of Multiple STI's and Respiratory Pathogens Diagnostic Accuracy of the New Zenit RA System for Detection of Celiac Disease-Related Antibodies and Automated Application of a Reflex Algorithm in IgA-Deficient Celiac Patients Molecular and Serological HBV Markers as Drivers of Individualized Patients Care HbA 1C : New Breakthrough Technology for Laboratories Facing a Change of Paradigm Using Active B12 (holotranscobalamin) to Diagnose Vitamin B12 Deficiency New Breakthrough Technology for Laboratories Facing a Change of Paradigm From Clinical Chemistry to Molecular Diagnostics: Innovative Solutions for Laboratory Automation and Organisation New Horizons in Cellular Analysis Diagnostic and Clinical Importance of Measuring Vitamin D Total Troponin T High Sensitive: Applying the Guidelines to Hospital's Daily Life Utility of Reflex Urine Culture Based on Results of Urinalysis and Automated Microscopy Using the Iris IQ200 Platform TLA – The ‘Lean’ Alternative Increasing Testing Efficieny in Laboratory Organizations from Pre to Post-Analytics Counting the Cost of the Preanalytical Phase New High-Performance Assays for the Determination of Free Light Chains Kappa and Lambda – Adding Consistency to Monitoring and Screening of Multiple Myeloma Clinical MSMS – New Developments in Today's Laboratory The Use of Multiplex Assays for Determining Predisposition to Hypertension Novel Markers in Reproductive Endocrinology FreeliteTM and HevyliteTM in Monoclonal Gammopathies: Improving Diagnosis, Monitoring and Prognosis Assessment Vitamin D Dietary Reference Intakes: Implications and Significance in Clinical Practice Roche – Delivering on the Promise of Personalised Healthcare Photometric Assays for Determination of Sodium, Potassium, Chloride and Lithium Current and Future Perspectives in Drugs of Abuse Screening; The Multiplex Approach Traceability and Uncertainty of Catalytic Activity Measurements